Gili Hart

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Opko Biologics Ltd., Prolor Biotech Ltd., Opko Biologies Ltd.. Active years: 2013-2025.

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 96(Granted Patents)

Company Filing History:

Years Active: 2013-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12203113 - Long-acting coagulation factors and methods of producing same (2025-01-21),

2. 11066658 - Long-acting coagulation factors and methods of producing same (2021-07-20),

3. 10960058 - Long-acting coagulation factors and methods of producing same (2021-03-30),

4. 10640758 - Long-acting coagulation factors and methods of producing same (2020-05-05),

5. 10538755 - Long-acting coagulation factors and methods of producing same (2020-01-21),

6. 10144921 - Long-acting coagulation factors and methods of producing same (2018-12-04),

7. 10119132 - Long-acting coagulation factors and methods of producing same (2018-11-06),

8. 9828417 - Long-acting polypeptides and methods of producing and administering same (2017-11-28),

9. 9663778 - Long-acting coagulation factors and methods of producing same (2017-05-30),

10. 9458444 - Long-acting coagulation factors and methods of producing same (2016-10-04),

11. 9249407 - Long-acting coagulation factors and methods of producing same (2016-02-02),

12. 8759292 - Long-acting coagulation factors and methods of producing same (2014-06-24),

13. 8476234 - Long-acting coagulation factors and methods of producing same (2013-07-02),

Title: Gili Hart: Innovator in Coagulation Factors

Introduction

Gili Hart is a prominent inventor based in Shoham, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of long-acting coagulation factors. With a total of 13 patents to his name, Hart's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents, Gili Hart has developed polypeptides that comprise at least one carboxy-terminal peptide (CTP) of chorionic gonadotrophin. These polypeptides are attached to the carboxy terminus but not to the amino terminus of a coagulation factor. Additionally, he has disclosed polynucleotides encoding these polypeptides. His inventions also include pharmaceutical compositions that utilize these polypeptides and polynucleotides, along with methods for their production and use.

Career Highlights

Gili Hart has worked with notable companies in the biotechnology sector, including Opko Biologics Ltd. and Prolor Biotech Ltd. His experience in these organizations has allowed him to refine his expertise in the development of innovative medical solutions.

Collaborations

Gili Hart has collaborated with Udi Eyal Fima, further enhancing his research and development efforts in the field of biotechnology.

Conclusion

Gili Hart's contributions to the field of coagulation factors and his extensive patent portfolio highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.